Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
Background and objective The treatment mode of lung cancer is epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) as a first-line treatment for patients with EGFR mutant in non-small cell lung cancer (NSCLC). At the same time programmed death receptor 1 (PD-1) and its programmed...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Chinês |
| Опубліковано: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-09-01
|
| Серія: | Chinese Journal of Lung Cancer |
| Предмети: | |
| Онлайн доступ: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.31 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|